Equities

eFFECTOR Therapeutics Inc

eFFECTOR Therapeutics Inc

Actions
  • Price (USD)0.0433
  • Today's Change0.001 / 1.76%
  • Shares traded7.74k
  • 1 Year change-99.67%
  • Beta0.6231
Data delayed at least 15 minutes, as of Sep 20 2024 20:54 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects eFFECTOR Therapeutics Inc share price to rise to 10.00 in the next year from the last price of 0.0433.
High23,021.4%10.00
Med23,021.4%10.00
Low23,021.4%10.00

Earnings history & estimates in USD

On May 09, 2024, eFFECTOR Therapeutics Inc reported 1st quarter 2024 losses of -2.16 per share. This result was in line with the consensus of the 2 analysts following the company and exceeded last year's 1st quarter results by 64.00%.
Average growth rate+21.08%
eFFECTOR Therapeutics Inc reported annual 2023 losses of -16.37 per share on Mar 25, 2024.
Average growth rate-19.05%
More ▼

Revenue history & estimates in USD

eFFECTOR Therapeutics Inc did not report revenues for the 1st quarter 2024. However, during the 1st quarter of the prior year the company reported revenues of 0.00.
Average growth rate0.00%
eFFECTOR Therapeutics Inc did not report revenues for the full year 2023. However, during the prior year the company reported revenues of 3.55m.
Average growth rate+24.23%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.